COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE

The present invention relates to pyrazine and pyridine compounds useful as inhibitors of ATR protein kinase. The invention also relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating various diseases, disorders, and conditions using the co...

Full description

Saved in:
Bibliographic Details
Main Authors DURRANT, STEVEN, JOHN, YOUNG, STEPHEN, CLINTON, STORCK, PIERRE-HENRI, REAPER, PHILIP, MICHAEL, CHARRIER, JEAN-DAMIEN, PINDER, JOANNE, VIRANI, ANIZA, NIZARALI
Format Patent
LanguageEnglish
French
Published 17.11.2011
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention relates to pyrazine and pyridine compounds useful as inhibitors of ATR protein kinase. The invention also relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating various diseases, disorders, and conditions using the compounds of this invention; processes for preparing the compounds of this invention; intermediates for the preparation of the compounds of this invention; and methods of using the compounds in in vitro applications, such as the study of kinases in biological and pathological phenomena; the study of intracellular signal transduction pathways mediated by such kinases; and the comparative evaluation of new kinase inhibitors. The compounds of this invention have formula (V): (Formula (v)) wherein the variables are as defined herein. La présente invention concerne des composés de pyrazine et de pyridine utilisables en tant qu'inhibiteurs de la protéine kinase ATR. L'invention concerne également des compositions pharmaceutiquement acceptables contenant les composés de l'invention ; des méthodes de traitement de divers troubles, maladies et affections faisant appel aux composés de l'invention ; des procédés de préparation des composés de l'invention ; des intermédiaires utilisables en vue de la préparation des composés de l'invention ; et des méthodes d'utilisation desdits composés dans des applications in vitro, par exemple l'étude des kinases dans des phénomènes biologiques et pathologiques ; l'étude des voies de transduction des signaux intracellulaires à médiation par lesdites kinases ; et l'évaluation comparative d'inhibiteurs inédits des kinases. Les composés de la présente invention sont de formule (V) : (Formule (V)) dans laquelle les variables sont telles que définies ici.
AbstractList The present invention relates to pyrazine and pyridine compounds useful as inhibitors of ATR protein kinase. The invention also relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating various diseases, disorders, and conditions using the compounds of this invention; processes for preparing the compounds of this invention; intermediates for the preparation of the compounds of this invention; and methods of using the compounds in in vitro applications, such as the study of kinases in biological and pathological phenomena; the study of intracellular signal transduction pathways mediated by such kinases; and the comparative evaluation of new kinase inhibitors. The compounds of this invention have formula (V): (Formula (v)) wherein the variables are as defined herein. La présente invention concerne des composés de pyrazine et de pyridine utilisables en tant qu'inhibiteurs de la protéine kinase ATR. L'invention concerne également des compositions pharmaceutiquement acceptables contenant les composés de l'invention ; des méthodes de traitement de divers troubles, maladies et affections faisant appel aux composés de l'invention ; des procédés de préparation des composés de l'invention ; des intermédiaires utilisables en vue de la préparation des composés de l'invention ; et des méthodes d'utilisation desdits composés dans des applications in vitro, par exemple l'étude des kinases dans des phénomènes biologiques et pathologiques ; l'étude des voies de transduction des signaux intracellulaires à médiation par lesdites kinases ; et l'évaluation comparative d'inhibiteurs inédits des kinases. Les composés de la présente invention sont de formule (V) : (Formule (V)) dans laquelle les variables sont telles que définies ici.
Author STORCK, PIERRE-HENRI
REAPER, PHILIP, MICHAEL
YOUNG, STEPHEN, CLINTON
PINDER, JOANNE
VIRANI, ANIZA, NIZARALI
CHARRIER, JEAN-DAMIEN
DURRANT, STEVEN, JOHN
Author_xml – fullname: DURRANT, STEVEN, JOHN
– fullname: YOUNG, STEPHEN, CLINTON
– fullname: STORCK, PIERRE-HENRI
– fullname: REAPER, PHILIP, MICHAEL
– fullname: CHARRIER, JEAN-DAMIEN
– fullname: PINDER, JOANNE
– fullname: VIRANI, ANIZA, NIZARALI
BookMark eNrjYmDJy89L5WTQcfb3DfAP9XMJVggNdnUL9VFwDFbw9PPwdPIM8Q8KVvB3U3AMCVLw9vRzDHblYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXx4f5GBoaGhibGJkbGjkbGxKkCACOuJ78
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate COMPOSÉS UTILISABLES EN TANT QU'INHIBITEURS DE LA KINASE ATR
ExternalDocumentID WO2011143423A2
GroupedDBID EVB
ID FETCH-epo_espacenet_WO2011143423A23
IEDL.DBID EVB
IngestDate Fri Jul 19 15:59:28 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_WO2011143423A23
Notes Application Number: WO2011US36243
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20111117&DB=EPODOC&CC=WO&NR=2011143423A2
ParticipantIDs epo_espacenet_WO2011143423A2
PublicationCentury 2000
PublicationDate 20111117
PublicationDateYYYYMMDD 2011-11-17
PublicationDate_xml – month: 11
  year: 2011
  text: 20111117
  day: 17
PublicationDecade 2010
PublicationYear 2011
RelatedCompanies STORCK, PIERRE-HENRI
REAPER, PHILIP, MICHAEL
YOUNG, STEPHEN, CLINTON
PINDER, JOANNE
VIRANI, ANIZA, NIZARALI
CHARRIER, JEAN-DAMIEN
DURRANT, STEVEN, JOHN
VERTEX PHARMACEUTICALS INCORPORATED
RelatedCompanies_xml – name: REAPER, PHILIP, MICHAEL
– name: YOUNG, STEPHEN, CLINTON
– name: VERTEX PHARMACEUTICALS INCORPORATED
– name: VIRANI, ANIZA, NIZARALI
– name: STORCK, PIERRE-HENRI
– name: CHARRIER, JEAN-DAMIEN
– name: DURRANT, STEVEN, JOHN
– name: PINDER, JOANNE
Score 2.830498
Snippet The present invention relates to pyrazine and pyridine compounds useful as inhibitors of ATR protein kinase. The invention also relates to pharmaceutically...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Title COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20111117&DB=EPODOC&locale=&CC=WO&NR=2011143423A2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp-J0SkDpk8Wu6-fDkC5t6cQ1pR-6t9GuKQgyh6v473uNm-5pIYSQwOUDfpe7S-4CcKcbOVe4asgIJlVG-ZbLtskHWJgWV9Rc5eK3hkloBJn2NNWnLXjf-MKIOKHfIjgiImqOeK8Fv17-G7Fc8bZy9VC8YdPHo58OXancmPswmZI7GnoRcxmVKEW9TQrj3z6tCXfnIMPeQ0HabPDgvYwav5Tl9qHiH8N-hPQW9Qm0-KIDh3Tz91oHDibrK2-srtG3OoV7yiYRy0I3IVni-dkzcRIyDoPxaJyyOCHMJ04aE1TIncQ7g1vfS2kg47Czv1XOXtn2HAfn0Eb9n18A6es5MtTCrpS5opWGaXNUkirdsio1L6qy34XeLkqXu7uv4EiYSZts9qBdf37xazxn6-JGbM8PaGx7TQ
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFOebTsXp1IDSJ4td18-HIV0_aHVtxtrq3ka7pSDIHK7iv-81rrqnhRBCApcP-F3uLrkLwJ2qZUxisiYimGQR5VsmmjrrY6EbTJIzmfHfGsJI81PlaapOG_Be-8LwOKHfPDgiImqOeC85v179G7Ec_rZy_ZC_YdPHo5cMHGFRm_sw6YIzHLhj6lBbsG3U24Ro8tunVOHuLGTYeyhk6xUe3Jdh5Zey2j5UvCPYHyO9ZXkMDbZsQ8uu_15rw0G4ufLG6gZ96xO4t2k4pmnkxCSNXS8dESsmQeQHwyChk5hQj1jJhKBCbsXuKdx6bmL7Ig47-1vl7JVuz7F_Bk3U_9k5kJ6aIUPNzUKaS8pC002GSlKhGkYhZ3mx6HWgu4vSxe7uG2j5STiajYLo-RIOucm0ynoXmuXnF7vCM7fMr_lW_QBcH35A
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=COMPOUNDS+USEFUL+AS+INHIBITORS+OF+ATR+KINASE&rft.inventor=DURRANT%2C+STEVEN%2C+JOHN&rft.inventor=YOUNG%2C+STEPHEN%2C+CLINTON&rft.inventor=STORCK%2C+PIERRE-HENRI&rft.inventor=REAPER%2C+PHILIP%2C+MICHAEL&rft.inventor=CHARRIER%2C+JEAN-DAMIEN&rft.inventor=PINDER%2C+JOANNE&rft.inventor=VIRANI%2C+ANIZA%2C+NIZARALI&rft.date=2011-11-17&rft.externalDBID=A2&rft.externalDocID=WO2011143423A2